Clinical Trials

Cancer Treatment Immunotherapy Patient Outcomes Stem Cell Therapy Drug Development Innovative Treatments Alzheimer's Disease Transplantation Studies Drug Efficacy Study Findings

3 ARTICLES

2w ago

AI Stratification Uncovers Alzheimer’s Drug Efficacy, Drives NHS Toward Precision Trials

Retrospective AI analysis of AMARANTH data revealed a 46% slower decline in slow-progressors treated with lanabecestat, prompting NHS Innovation East England to fund clinical integration.

6 ARTICLES

2w ago

New Low-Cost Methods Enable Heart Transplants After Circulatory Death

3 ARTICLES

2w ago

UNM Launches Phase 1a/1b Trial of Tau-Targeting Alzheimer’s Vaccine

4 ARTICLES

3w ago

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

5 ARTICLES

4w ago

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

3 ARTICLES

last mo.

Tata Memorial to Routinely Offer Ultra-High Dose MIBG Therapy After Teen’s Remission

3 ARTICLES

last mo.

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free

3 ARTICLES

last mo.

Zigakibart sustains proteinuria remission and stabilizes kidney function over 100-week IgA nephropathy trial

5 ARTICLES

2mo ago

ASCO Conference Showcases Lifestyle-Adapted Immunotherapy and Promising Cancer Vaccines

3 ARTICLES

2mo ago

Temple Hospital Rolls Out Automated EMR Tool for Early Pulmonary Hypertension Detection

3 ARTICLES

2mo ago

Pivekimab Sunirine Shows 85% Response Rate in BPDCN Trial

3 ARTICLES

2mo ago

Pre-Surgery Nivolumab and Chemotherapy Improve Five-Year Survival in Operable Lung Cancer

3 ARTICLES

2mo ago

Avelumab and Cetuximab Combo Quadruples Progression-Free Survival in Advanced cSCC

Particle.news

Clinical Trials

AI Stratification Uncovers Alzheimer’s Drug Efficacy, Drives NHS Toward Precision Trials

New Low-Cost Methods Enable Heart Transplants After Circulatory Death

UNM Launches Phase 1a/1b Trial of Tau-Targeting Alzheimer’s Vaccine

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

Tata Memorial to Routinely Offer Ultra-High Dose MIBG Therapy After Teen’s Remission

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free

India to Link Rare Blood Donor Registry With e-Rakt Kosh

Eric Dane Confronts ALS Progression With Loss of Right Arm Function

NHS App Expands to Let Patients Browse and Join Clinical Trials

Never miss stories about

Clinical Trials

IFN-γ Receptor Knockout Extends CAR-T Cell Lifespan and Boosts Tumor Combat

Extended CT Scans Uncover Hidden Stroke Clots and Drive Plans for Global Trial

Italy Rolls Out Weekly Insulin Therapy Despite Regional Disparities

CrossNN AI Model Classifies Over 170 Cancer Types From Liquid Biopsies

Zigakibart sustains proteinuria remission and stabilizes kidney function over 100-week IgA nephropathy trial

ASCO Conference Showcases Lifestyle-Adapted Immunotherapy and Promising Cancer Vaccines

Temple Hospital Rolls Out Automated EMR Tool for Early Pulmonary Hypertension Detection

Pivekimab Sunirine Shows 85% Response Rate in BPDCN Trial

Pre-Surgery Nivolumab and Chemotherapy Improve Five-Year Survival in Operable Lung Cancer

Avelumab and Cetuximab Combo Quadruples Progression-Free Survival in Advanced cSCC

Never miss stories about

Clinical Trials